MoneyWorks4Me

Aurobindo Pharma informs about press release

23 Nov 2022 Evaluate

Aurobindo Pharma has informed that it enclosed Press Release issued by Acrotech Biopharma LLC, a step-down wholly owned subsidiary of the Company on entering into a license agreement with Evive Biotech to commercialize Ryzneuta™ (Efbemalenograstim alfa) in the US.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..